NCT03726450 is a NA clinical trial of Andrositol Plus in Male Infertility, sponsored by Andrology and Fertility Hospital of Hanoi.

Who is sponsoring NCT03726450?

NCT03726450 is sponsored by Andrology and Fertility Hospital of Hanoi.

What drugs are being tested in NCT03726450?

Interventions in NCT03726450: Andrositol Plus, Andrositol Plus, Andrositol Plus, Andrositol Plus, Andrositol Plus, Andrositol Plus, Andrositol Plus.

What condition does NCT03726450 study?

NCT03726450 studies Male Infertility.

Is NCT03726450 still recruiting?

NCT03726450 is currently status unknown. Last updated 12 December 2019.

Last reviewed 2019-12-12 · How we verify

NCT03726450

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Myo-inositol and an Antioxidant Mix for the Treatment of Vietnamese Infertile Men

Status unknown NA Last updated 12 December 2019

What this trial tests

NA trial testing Andrositol Plus in Male Infertility in 55 participants. Status unknown.

Timeline

1 November 2018

Primary endpoint
1 February 2020

1 March 2020

Quick facts

Lead sponsor	Andrology and Fertility Hospital of Hanoi
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	55
Start date	1 November 2018
Primary completion	1 February 2020
Estimated completion	1 March 2020
Sites	1 location across Vietnam

Drugs / interventions tested

Andrositol Plus
Andrositol Plus
Andrositol Plus
Andrositol Plus
Andrositol Plus
Andrositol Plus
Andrositol Plus

Conditions studied

Male Infertility — all drugs for Male Infertility →

Sponsor

Andrology and Fertility Hospital of Hanoi

Who can join

Adults 18 to 55, male only, with Male Infertility. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to evaluate if Myo-inositol, N-Acetyl-Cysteine plus a cocktail of antioxidants could be able to increase spermatozoa parameters and reduce semen hyper-viscosity

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Male Infertility

Currently open trials in the same condition.

NCT07375238 — Effect of Daily Intake of Gazpacho on Semen Quality and Oxidative Stress · NA · recruiting
NCT07369362 — To Investigate if the Harvester® Improves Sperm Motility and Blastocyst Utilization (the Percent of Fertilized Eggs That · NA · active not recruiting
NCT06956287 — The Efficiency of a New Sperm-Wash Device for Intrauterine Insemination in Couples With Infertility · NA · recruiting
NCT06561451 — Live Birth Rate Between ICSI and AOA and ICSI Alone in Patients With Severe Teratospermia · NA · recruiting
NCT07056400 — Trial to Improve Fertilization Rate and Embryo Development in Intracytoplasmic Sperm Injection (ICSI) Cycles · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03726450 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Andrology and Fertility Hospital of Hanoi
Last refreshed: 12 December 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03726450.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing